North America In Vitro Diagnostics (IVD) Quality Control Market (2025-2030)
The North America In Vitro Diagnostics (IVD) Quality Control Market was valued at $255.5 Million in 2025 and projected to reach to $367.4 Million by 2030, representing a compound annual growth rate of 7.5%. The North American IVD Quality Control Market is poised for sustained expansion, driven by increasing diagnostic testing volumes, heightened regulatory scrutiny, and widespread laboratory modernization initiatives.
North America In Vitro Diagnostics (IVD) Quality Control Market Trends and Insights
- Asia Pacific's market growth significantly outpaces the global average of 5.5%, driven by increasing diagnostic testing volumes, regulatory compliance requirements, and healthcare infrastructure modernization across the region.
- The region's expanding middle class and rising prevalence of chronic diseases are accelerating demand for reliable quality control solutions in clinical laboratories and diagnostic centers. Asia Pacific's IVD quality control sector benefits from rapid adoption of automation and digital technologies in laboratory settings.
- Countries within Asia Pacific are investing heavily in healthcare diagnostics to improve disease detection and patient outcomes, creating sustained demand for quality assurance products and services.
- The region's competitive manufacturing landscape and cost-effective solutions position Asia Pacific as a critical growth engine for the global IVD quality control market through 2030..
Key Market Statistics
- CAGR (2025-2030) 7.5% CAGR
- Market Size, 2025 ~USD 255.5 Million
- Forecast, 2030 ~USD 367.4 Million
- Geography North America
North America In Vitro Diagnostics (IVD) Quality Control Market Overview
Dominant US Market Leadership :
The United States commands the North American IVD quality control market with a valuation of USD 709.6 million, representing the largest regional contributor and driving innovation in diagnostic testing standards and regulatory compliance frameworks.
Strong Regional CAGR Performance :
North America's 7.5% CAGR significantly exceeds the global average of 5.5%, reflecting accelerated adoption of advanced quality control solutions across clinical laboratories, blood banks, and diagnostic centers throughout the region.
Canada's Growing Market Contribution :
Canada represents a secondary but expanding market valued at USD 77.06 million, driven by stringent healthcare regulations, increasing laboratory automation, and rising demand for quality assurance in diagnostic testing procedures.
Regulatory Compliance Driving Growth :
Stringent FDA regulations, CLIA requirements, and CAP accreditation standards in North America are propelling investments in quality control systems, creating sustained demand for advanced IVD quality assurance solutions and services.
North America In Vitro Diagnostics (IVD) Quality Control Market Dynamics
- The region's mature healthcare infrastructure and emphasis on patient safety standards create a robust foundation for quality control solution adoption.
- With the US market leading at USD 709.6 million and Canada contributing USD 77.06 million, the combined North American market demonstrates strong momentum. Looking ahead to 2030, North America's 7.5% CAGR trajectory reflects growing investments in laboratory automation, digital quality management systems, and integrated diagnostic platforms.
- Factors including an aging population, rising chronic disease prevalence, and the shift toward point-of-care testing are expected to sustain demand for comprehensive quality control solutions.
- Healthcare providers' commitment to reducing diagnostic errors and improving operational efficiency will continue to drive market expansion throughout the forecast period..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Asia Pacific IVD Quality Control Market will grow from USD 255.5M (2025) to USD 367.4M (2030) at a 7.5% CAGR, outpacing global growth.
- Asia Pacific's rapid healthcare infrastructure development and regulatory tightening are primary drivers of quality control adoption across the region.
- Automation and digital laboratory technologies are transforming Asia Pacific's diagnostic quality assurance landscape.
- Asia Pacific represents a high-growth opportunity for IVD quality control vendors seeking expansion beyond mature Western markets.
In Vitro Diagnostics (IVD) Quality Control Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOLECULAR DIAGNOSTICS (Technology) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.5% from 2025 to 2030 |
| Largest Segment | QUALITY CONTROL PRODUCTS (Product & Service) |
| Market Size Base Year (Billions) | ~USD 1.65 (2025) |
| Revenue Forecast (Billions) | ~USD 2.15 (2030) |
| Segments Covered | Product & Service, Type, Technology, Manufacturer Type, End User |
North America In Vitro Diagnostics (IVD) Quality Control Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Data Management Solutions
- Quality Assurance Services
- Quality Control Products
By Type
- Independent Controls
- Instrument-Specific Controls
- Other Controls
- Serum/Plasma-Based Controls
- Urine-Based Controls
- Whole Blood-Based Controls
By Technology
- Clinical Chemistry
- Coagulation & Hemostasis
- Hematology
- Immunoassays
- Microbiology
- Molecular Diagnostics
- Other Technologies
By Manufacturer Type
- Original Equipment Manufacturer Controls
- Third-Party Controls
By End User
- Academic & Research Institutes
- Clinical Laboratories
- Hospitals
- Other End Users
Target Audience
- Diagnostic Equipment Manufacturers : IVD equipment producers need North American market data to develop quality control-integrated solutions compliant with FDA and CLIA standards, and to identify growth opportunities in the USD 709.6M US market.
- Laboratory Service Providers : Clinical laboratories and diagnostic centers require market insights to justify investments in advanced quality control systems, benchmark operational costs, and align with regulatory compliance requirements across North America.
- Quality Control Software Vendors : Software and digital solution providers need regional market intelligence to position quality management platforms, understand adoption rates, and develop region-specific features for North American laboratory workflows.
- Healthcare System Administrators : Hospital networks and integrated healthcare systems need market data to evaluate quality control technology investments, understand competitive offerings, and optimize diagnostic accuracy and operational efficiency.
- Investment and Strategy Consultants : Private equity, venture capital, and management consulting firms require detailed North American market analysis to identify acquisition targets, assess growth potential, and guide portfolio company strategies in the IVD sector.
Key Companies in the North America In Vitro Diagnostics (IVD) Quality Control Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BIOMERIEUX S.A. | France | Public Company | Clinical microbiology (VITEK, culture media, ID/AST, BACT/ALERT),Syndromic and molecular diagnostics (BIOFIRE, SPOTFIRE, ARGENE, NUCLISENS),Immunoassays and biomarkers (VIDAS, Hybiome CLIA, sepsis markers), |
| CEPHEID INC. | United States | Private Company | GeneXpert instruments and Xpert test cartridges,SmartCycler systems and assays,Collaborative and program-based solutions (e.g., TB, Ebola, USPS BDS), |
| IMMUCOR, INC. | United States | Private Company | Transfusion (serology instruments and reagents),Transplant & Molecular (HLA, HEA/HPA typing, Array Imaging System),Platelet-focused and specialty coagulation products, |
| DIASORIN | Italy | Public Company | Immunodiagnostics – Infectious and Gastrointestinal Diseases,Immunodiagnostics – Endocrinology and Metabolic Disorders,Oncology and Tumor Markers, |
| UNILABS | Switzerland | Private Company | Core laboratory testing,Medical imaging services,Pathology and centres of excellence, |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Clinical Diagnostics,Life Science Research Instruments and Reagents,Other and Services, |
| THERMO FISHER SCIENTIFIC, INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| ABBOTT | United States | Public Company | Diagnostic Products (core lab, rapid, molecular, cardiometabolic, drug testing),Medical Devices (cardiovascular, diabetes care, neuromodulation),Nutritional Products (pediatric, adult, infant formula), |
| LGC LIMITED | South Korea | Public Company | Ethylene-based synthetic resins (EVA, HDPE, LDPE, LLDPE, POE, metallocene PE, UNIQABLE),Styrene-based resins (ABS, ASA, EPS, PS, SAN),Polycarbonate and polypropylene, |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| QUIDELORTHO CORPORATION | United States | Public Company | Labs (clinical chemistry and immunoassay),Transfusion Medicine,Point of Care (professional and OTC), |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicines),Diagnostics (clinical instruments and consumables), |
| SYSMEX CORPORATION | Japan | Public Company | Hematology analyzers and reagents (XN-Series, XN-V, ProCyte Dx),Coagulation systems and reagents,Blood gas, electrolyte, and urinalysis analyzers, |
| BIO-TECHNE CORPORATION | United States | Public Company | Protein Sciences reagents (cytokines, growth factors, antibodies, small molecules, sera, cell selection),Proteomic and protein analysis instruments and immunoassays,Diagnostics products, controls, calibrators, and assays, |
| MICROBIX BIOSYSTEMS INC. | Canada | Public Company | Antigen and test ingredient business,QAPs branded test controls and quality assessment products,DxTM viral transport medium, |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
BIOMERIEUX S.A.
bioMérieux S.A. is a French public company founded in 1963 that employs 14,894 people. The company operates in the diagnostics and life sciences sector.
CEPHEID INC.
Cepheid Inc. is a private company founded in 1996 in the United States with 1,700 employees. The company specializes in molecular diagnostics and infectious disease testing.
IMMUCOR, INC.
Immucor, Inc. is a private company founded in 1982 in the United States with 1,125 employees. The company focuses on blood bank and transfusion diagnostics.
DIASORIN
DiaSorin is an Italian public company founded in 1968 with 3,242 employees. The company operates in the in vitro diagnostics sector.
UNILABS
Unilabs is a private company founded in 1987 in Switzerland with 1,897 employees. The company provides laboratory and diagnostic services.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a public company founded in 1952 in the United States with 7,450 employees. The company develops and manufactures life science research and clinical diagnostics products.
THERMO FISHER SCIENTIFIC, INC.
Thermo Fisher Scientific, Inc. is a public company founded in 1956 in the United States with 125,000 employees. The company is a global leader in serving science with laboratory equipment, reagents, and analytical instruments.
ABBOTT
Abbott is a public company founded in 1888 in the United States with 115,000 employees. The company operates in diagnostics, medical devices, pharmaceuticals, and nutritional products.
LGC LIMITED
LGC Limited is a public company founded in 1947 in South Korea with 14,019 employees. The company provides testing, proficiency testing, and reference materials services.
SIEMENS HEALTHINEERS AG
Siemens Healthineers AG is a public company founded in 1896 in Germany with 72,369 employees. The company provides medical imaging, laboratory diagnostics, and point-of-care testing solutions.
QUIDELORTHO CORPORATION
QuidelOrtho Corporation is a public company founded in 1979 in the United States with 6,500 employees. The company develops and manufactures rapid diagnostic tests and molecular testing solutions.
DANAHER CORPORATION
Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees. The company operates across diagnostics, life sciences, and environmental and applied solutions segments.
SYSMEX CORPORATION
Sysmex Corporation is a public company founded in 1968 in Japan with 10,861 employees. The company manufactures hematology analyzers and other in vitro diagnostic systems.
BIO-TECHNE CORPORATION
Bio-Techne Corporation is a public company founded in 1976 in the United States with 3,100 employees. The company develops and manufactures life science tools and bioanalytical instruments.
MICROBIX BIOSYSTEMS INC.
Microbix Biosystems Inc. is a public company founded in 1988 in Canada with 100 employees. The company produces quality control materials and reference standards for diagnostics.
GRIFOLS, S.A.
Grifols, S.A. is a public company founded in 1909 in Spain with 25,000 employees. The company specializes in blood plasma derivatives and diagnostic products.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 709.6 Million |
| Canada | USD 77.06 Million |
Country market size visualization
Reasons to Buy this Report
- Comprehensive Regional Market Sizing : Access detailed market valuations for the US (USD 709.6M) and Canada (USD 77.06M), enabling precise investment decisions and competitive positioning strategies specific to North American IVD quality control segments.
- Growth Trajectory Analysis : Understand North America's 7.5% CAGR outperformance versus global 5.5% average, identifying high-growth opportunities and market dynamics unique to the region's regulatory environment and healthcare infrastructure.
- Regulatory Landscape Intelligence : Gain insights into FDA, CLIA, and CAP compliance requirements driving quality control adoption across North American laboratories, enabling compliant product development and market entry strategies.
- Competitive Market Positioning : Benchmark your organization against regional market trends, identify white-space opportunities in the USD 786.66M combined North American market, and develop targeted go-to-market strategies.
- Forecast-Driven Strategic Planning : Leverage 2030 projections and CAGR data to inform 5-year business plans, capital allocation decisions, and product development roadmaps aligned with North American market expansion opportunities.
Frequently asked questions
What is the current market size of IVD Quality Control in Asia Pacific?
The Asia Pacific IVD Quality Control Market was valued at USD 255.5 million in 2025 and is expected to grow to USD 367.4 million by 2030.
What is the projected CAGR for Asia Pacific's IVD Quality Control Market?
Asia Pacific's IVD Quality Control Market is projected to grow at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2030.
How does Asia Pacific's growth compare to the global IVD Quality Control Market?
Asia Pacific's 7.5% CAGR significantly exceeds the global market CAGR of 5.5%, making the region a faster-growing segment.
What factors are driving growth in Asia Pacific's IVD Quality Control Market?
Key drivers include increasing diagnostic testing volumes, stricter regulatory compliance requirements, healthcare infrastructure modernization, rising chronic disease prevalence, and adoption of laboratory automation technologies across Asia Pacific.
Which countries in Asia Pacific are leading the IVD Quality Control Market expansion?
Major contributors to Asia Pacific's market growth include China, India, Japan, South Korea, and Southeast Asian nations, driven by their expanding healthcare systems and diagnostic capabilities.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global IVD quality controls market.
Exhaustive secondary research was done to collect information on the IVD quality controls market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the IVD quality controls market.
The four steps involved in estimating the market size are as follows:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. Here’s the breakdown of tiers: Tier 1 = > USD 100 million, tier 2 = USD 10 million to USD 100 million, and tier 3 = < USD 10 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the IVD quality controls market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size included the following:
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
IVD quality controls are standardized materials used to monitor, evaluate, and ensure the accuracy, reliability, and precision of diagnostic testing processes in clinical laboratories. These controls are designed to mimic patient samples and are produced from human-derived matrices such as serum, plasma, urine, or whole blood. IVD quality controls provide a benchmark for validating test system performance, detecting errors, and ensuring regulatory compliance across diverse diagnostic platforms.
Stakeholders
- Senior Management
- End Users
- Finance/Procurement Department
- R&D Department
Report Objectives
- To define, describe, segment, and forecast the global IVD quality controls market by product & service, technology, manufacturer type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall IVD quality controls market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the IVD quality controls market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
- To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region
Get the Full In Vitro Diagnostics (IVD) Quality Control Market Report
Full forecast, segment splits, and company analysis for all In Vitro Diagnostics (IVD) Quality Control Market.
- Canada In Vitro Diagnostics (IVD) Quality Control Market
- US In Vitro Diagnostics (IVD) Quality Control Market
- Germany In Vitro Diagnostics (IVD) Quality Control Market
- UK In Vitro Diagnostics (IVD) Quality Control Market
- France In Vitro Diagnostics (IVD) Quality Control Market
- Italy In Vitro Diagnostics (IVD) Quality Control Market
- Spain In Vitro Diagnostics (IVD) Quality Control Market
- Russia In Vitro Diagnostics (IVD) Quality Control Market
- China In Vitro Diagnostics (IVD) Quality Control Market
- Japan In Vitro Diagnostics (IVD) Quality Control Market
- India In Vitro Diagnostics (IVD) Quality Control Market
- Australia In Vitro Diagnostics (IVD) Quality Control Market
- South Korea In Vitro Diagnostics (IVD) Quality Control Market
- Brazil In Vitro Diagnostics (IVD) Quality Control Market
- Mexico In Vitro Diagnostics (IVD) Quality Control Market
- Saudi Arabia In Vitro Diagnostics (IVD) Quality Control Market
- UAE In Vitro Diagnostics (IVD) Quality Control Market
- Rest Of Europe In Vitro Diagnostics (IVD) Quality Control Market
- Rest Of Asia Pacific In Vitro Diagnostics (IVD) Quality Control Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report